EMEA-001705-PIP02-15-M03

Table of contents

Key facts

Invented name
Plenvu
Active substance
  • sodium sulfate
  • sodium chloride
  • sodium ascorbate
  • potassium chloride (NER1006)
  • ascorbic acid
  • Polyethylene glycol 3350
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0458/2020
PIP number
EMEA-001705-PIP02-15-M03
Pharmaceutical form(s)
Powder for oral solution
Condition(s) / indication(s)
Bowel cleansing prior to clinical procedures
Route(s) of administration
  • Oral use
  • Gastric use
Contact for public enquiries
Norgine Limited

Email: lifecyclemanagement@norgine.com    
Tel. +44 1895453584
+44 1895826669
 

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating